Skip to main content
NIH funding notice PAR-14-292

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)

Closed on March 9, 2017.

Posted
July 22, 2014
Close date
March 9, 2017
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $396,600 in first-year total cost, median $396,600.

Most frequent study sections

  1. Special Emphasis Panel[ZNS1 SRB-T (07)]1

Most frequent institutions

  1. KNOPP BIOSCIENCES, LLC1
Competing awards under PAR-14-292 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2016Kv7.2/7.3 Activators for the Treatment of Epilepsy Disorders1U44NS093160-01A1BOZIK, MICHAELKNOPP BIOSCIENCES, LLC, PA$396,600ZNS1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.